Keywords: orphan, drug, status, sugen, su101, inc, says

Orphan Drug Status For Sugen's SU101

Article | 25 March 1996

Sugen Inc says it has now received an orphan drug designation for its anticancer compound SU101 in the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in